Navigation Links
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at JPMorgan Conference
Date:1/9/2009

ROCKVILLE, Md., Jan. 9 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI) announced today that its presentation at the 27th Annual JPMorgan Healthcare Conference will be webcast and may be accessed at www.hgsi.com

(Logo: http://www.newscom.com/cgi-bin/prnh/20080416/HGSLOGO )

A member of Human Genome Sciences' senior management team will present an overview of the company on Wednesday, January 14, 2009 at 7:30 am Pacific Time (10:30 am Eastern Time).

Investors interested in listening to the live webcast should log on before the start time in order to download any software required. The archive of the webcast will be available for several weeks after the live event.

The mission of HGS is to apply great science and great medicine to bring innovative drugs to patients with unmet medical needs.

HGS and Human Genome Sciences are registered trademarks of Human Genome Sciences, Inc. For additional information on Human Genome Sciences, Inc., visit the company's web site at www.hgsi.com.


'/>"/>
SOURCE Human Genome Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Human Genome Sciences Announces Albuferon(R) Meets Primary Endpoint in Phase 3 Trial in Chronic Hepatitis C
2. HemoGenix(R), Inc Announces Implementation of ORF Genetics Human Growth Factors and Cytokines in All Human HALO(R) Assay Kits and Contract Research Services
3. ExonHit Launches Mouse Genome SpliceArray(TM) for use in Human Disease Modeling Studies
4. Video: 8-Minute Film Documentary Explores Why Humans Age
5. Scopus to Expand Arts & Humanities Coverage
6. Human clinical study demonstrates superior Neptune Krill Oil NKO(R) pharmacokinetic profile
7. Mexican Department of Public Health to Launch Screening for Human Papillomavirus (HPV), Cause of Cervical Cancer
8. Clinical Data Show Long-Acting Human Growth Hormone ARX201 is Safe and Well Tolerated
9. Human Pheromone Sciences Announces Third Quarter Results
10. Transdermal Diclofenac enters Phase 1 Clinical Trial in Humans
11. Interleukin Genetics to Present New Findings on Osteoporosis at the 58th Annual Meeting of the American Society of Human Genetics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2016)... 19, 2016 - I dati ... durante il 52 ° Congresso ... - Le conclusioni dello studio indicano un ... trattati, di cui il 90% presenta una d urata ... più. Il settantadue per cento dei pazienti ha riscontrato un ...
(Date:5/18/2016)... ... 18, 2016 , ... STACS DNA Inc., the sample tracking software company, today ... assault kit processing to help them save time and reduce errors. , Sexual Assault ... be processed and victims informed of results. Due to a previous lack of tools, ...
(Date:5/17/2016)... , May 18, 2016 Haselmeier ... prefilled pen following approval by EMA, the European Medicines ... science and technology company, the new pen version includes ... increased level of confidence to patients during use. ... prefilled pen easier to handle with a larger display ...
(Date:5/17/2016)... ... May 17, 2016 , ... The Children’s Tumor Foundation is enthusiastic to announce ... will show their support in the fight against neurofibromatosis (NF) by lighting up blue ... disorder that causes tumors to grow on nerves throughout the body. It affects 1 ...
Breaking Biology Technology:
(Date:4/15/2016)... April 15, 2016 Research ... Gait Biometrics Market 2016-2020,"  report to their offering.  ... ) , ,The global gait biometrics market is ... during the period 2016-2020. Gait analysis ... can be used to compute factors that are ...
(Date:4/13/2016)... April 13, 2016  IMPOWER physicians supporting Medicaid patients ... a new clinical standard in telehealth thanks to a ... the higi platform, IMPOWER patients can routinely track key ... body mass index, and, when they opt in, share ... visit to a local retail location at no cost. ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys has ... CEO, Barrett Bready , M.D., who returned to ... the original technical leadership team, including Chief Technology Officer, ... Product Development, Steve Nurnberg and Vice President of Software ... the company. Dr. Bready served as CEO ...
Breaking Biology News(10 mins):